David A. Siegel Ocugen, Inc. Transaction History
Two Sigma Advisers, LP
- $43.8 Billion
- Q2 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Ocugen, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 26,000 shares of OCGN stock, worth $28,080. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,000Holding current value
$28,080% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding OCGN
# of Institutions
108Shares Held
66.7MCall Options Held
516KPut Options Held
272K-
Black Rock Inc. New York, NY17.9MShares$19.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.5MShares$16.8 Million0.0% of portfolio
-
State Street Corp Boston, MA14.8MShares$16 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA5.9MShares$6.38 Million0.0% of portfolio
-
Rafferty Asset Management, LLC New York, NY1.08MShares$1.16 Million0.01% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $234M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...